(Q51550714)

6 April 2018

title

Treatment of familial hypertriglyceridaemia with acarbose. (English)

1 reference

6 April 2018

author name string

Malaguarnera M

1

1 reference

6 April 2018

Giugno I

2

1 reference

6 April 2018

Ruello P

3

1 reference

6 April 2018

Maugeri D

4

1 reference

6 April 2018

Pistone G

5

1 reference

6 April 2018

publication date

1 January 2000

1 reference

6 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

6 April 2018

volume

2

1 reference

6 April 2018

issue

1

1 reference

6 April 2018

page(s)

33-38

1 reference

6 April 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Myocardial infarction in the familial forms of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Suppression by diets rich in fish oil of very low density lipoprotein production in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Plasma triglyceride level and mortality from coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00065.X

10.1046/J.1463-1326.2000.00065.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

11220352

1 reference

6 April 2018